Lv4
480 积分 2023-11-08 加入
Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer
7天前
已完结
Bispecific antibodies in the treatment of relapsed/refractory large B-cell lymphoma
1个月前
已完结
CD22 CAR T-cell therapy: new hope for patients with large B-cell lymphoma
1个月前
已完结
Recent advances in understanding of pathogenesis and treatment development for diffuse large B-cell lymphoma and follicular lymphoma
2个月前
已完结
Molecular complexity of diffuse large B-cell lymphoma: a molecular perspective and therapeutic implications
2个月前
已完结
Casitas b cell lymphoma‑B (Cbl-b): A new therapeutic avenue for small-molecule immunotherapy
2个月前
已完结
Immune checkpoints in B-cell Lymphoma: Still an Unmet challenge from Basic research to clinical practice
2个月前
已完结
Antibody and immunotherapy in diffuse large B-cell lymphoma
2个月前
已完结
Efficacy and safety of KRAS G12C inhibitor IBI351 monotherapy in patients with advanced non-small cell lung cancer: results from a phase 2 pivotal study
5个月前
已完结
Targeting KRAS in cancer
5个月前
已完结
皖公网安备34019202002308
